The Food and Drug Administration (FDA) has approved Pfizer’s Paxlovid COVID-19 pill. A pill can be administered to adults and children 12 years or older who have been infected with Corona. A major advance in the fight against this epidemic has been achieved with the approval of this pill, according to Patricia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research. Patients who are infected with Corona will be given pills for the first time.
The antiviral Covid pill from Pfizer has been shown to be 90% effective in treating Corona. Using this drug can reduce the risk of death or hospitalization for patients at high risk. Additionally, this drug has also been found to be effective against the new Corona variant called Omicron.
People with Corona who take the tablet Paxlovid have a low risk of dying. A tablet, which was developed by FDA scientist Patrizia Cavazzoni, has been successfully used to treat Corona virus in many countries of the world. Corona virus is a form of Covid. This is a landmark moment in the global battle against Corona.
Chief Executive Officer and President of Pfizer Albert Borula said the results of testing this tablet on 2,200 people who were being treated for Corona in the hospital were unexpected. By taking tablets, you can reduce your risk of death by as much as 88 percent.
Working against Omicron
A variant of Omicron has just been detected. That is why the company has not tested it yet. While in the meantime, experts claim that since the way the tablet works differs slightly from antibodies or vaccines, this tablet will be effective even against Corona variants other than Omicron.
Is the Paxlovid pill at risk?
Paxlovid tablet was approved by the US Drug Controller USFDA committee. The committee members have all approved it. There have been no security risks identified by the committee. Protease is inhibited by Paxlovid Tablet. Proteinase is an enzyme that aids in virus replication.
In a week, the Centers for Disease Control and Prevention reported an increase in Omicron infections of nearly sixfold. Many parts of the country are even more prone to Omicron. In New York, the Southeast, Midwest, and the Pacific Northwest, Omicron is known to cause 90 percent of all new infections.